The 10 hottest medtech startups of 2017

RenovaCare

Technology: CellMist systems with SkinGun

CEO: Thomas Bold

Website: renovacareinc.com

RenovaCare’s flagship CellMist system has 2 components: The CellMist solution, a water-based solution with the patient’s own stem cells; and the SkinGun, an ultra-gentle spray device which deposits the CellMist solution. The technology offers an alternative to conventional skin graft surgery, which can be painful, prone to complications and slow to heal.

A small sample of the patient’s healthy skin is processed to liberate the stem cells from surrounding tissue. The cells are suspended in a water-based solution, placed into a syringe which is attached to the SkinGun. Within 90 minutes of a patient arriving in an emergency room, stem cells are isolated, processed and sprayed onto the wound site.

A wound heals from the edges to the middle, and the longer that takes, the higher is the risk for inflammation and finally scarring. CellMist creates thousands of little regenerative islands all over the wound. These islands connect to each other to heal the wound, resulting in skin that looks and functions as it did before.

CellMist is under investigational use in Europe and the United States.

7 companies in the race to make an artificial pancreas>>

From the Hospital Bed to the Finish Line Heidi Dohse was diagnosed with a rare arrhythmia in 1982 and has been 100% pacemaker dependent for over 30 years. With the help of wearable devices, she has been able to pursue her dream to become a competitive cyclist. You can hear her story and more when you register for DeviceTalks Boston, October 8-10. REGISTER NOW Use code FINISHLINE to save an additional 10%.